At the Milken Institute’s 2025 Future of Health Summit, FDA Commissioner Marty Makary reaffirmed that the U.S. ...
As we approach 2026, the life-sciences and healthcare sectors are entering a new chapter defined by consumer ...
Nitrosamines, classified as potential carcinogens, have remained a key focus for global regulators since their ...
Do you value EMMA International’s thought leadership, industry insights, and regulatory guidance? We’re pleased to ...
Contamination control involves strategies and systems designed to prevent unwanted materials—chemical or ...
Pharmaceutical manufacturers and industry organizations are urging the U.S. Food and Drug Administration (FDA) to ...
Artificial intelligence (AI) continues to reshape the medical technology landscape—particularly in clinical ...
The U.S. dietary supplement industry continues to face mounting legal scrutiny as consumer class action lawsuits ...
In a major step toward streamlining biosimilar development, the U.S. Food and Drug Administration (FDA) has ...
As artificial intelligence (AI) reshapes nearly every sector, regulatory professionals are beginning to confront a ...
As Halloween festivities come to a close, the U.S. Consumer Product Safety Commission (CPSC) has announced a ...
Contamination control involves strategies and systems designed to prevent unwanted materials—chemical or ...